SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 6th, 2011 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledJuly 6th, 2011 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of June 29, 2011, among Cell Therapeutics, Inc., a Washington corporation (the “Company”), and each purchaser identified on the signature pages hereto, including Rodman and Renshaw, LLC (“Rodman”), which is also acting as placement agent for the Company (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 5th, 2010 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledApril 5th, 2010 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of , 2010, among Cell Therapeutics, Inc., a Washington corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 19th, 2010 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledJanuary 19th, 2010 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of , 2010, among Cell Therapeutics, Inc., a Washington corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 21st, 2009 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 21st, 2009 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of , 2009, among Cell Therapeutics, Inc., a Washington corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 5th, 2008 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 5th, 2008 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of March 3, 2008, among Cell Therapeutics, Inc., a Washington corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).